I. King

665 total citations
13 papers, 552 citations indexed

About

I. King is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, I. King has authored 13 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in I. King's work include Cancer Research and Treatments (3 papers), Cancer therapeutics and mechanisms (3 papers) and Virus-based gene therapy research (2 papers). I. King is often cited by papers focused on Cancer Research and Treatments (3 papers), Cancer therapeutics and mechanisms (3 papers) and Virus-based gene therapy research (2 papers). I. King collaborates with scholars based in United States, United Kingdom and France. I. King's co-authors include Alan C. Sartorelli, David Bermudes, Xiaobo Luo, Jeremy A. Pike, Limin Zheng, Stephen M. Brecher, Z. Li, K. Brooks Low, Caroline Clairmont and John M. Pawelek and has published in prestigious journals such as Journal of Controlled Release, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

I. King

13 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. King United States	8	307	228	193	185	59	13	552
K.S. Wun Australia	10	118 0.4×	96 0.4×	208 1.1×	39 0.2×	168 2.8×	11	971
Daniel Hopkins United States	9	102 0.3×	53 0.2×	464 2.4×	34 0.2×	35 0.6×	15	589
Ginette Balboni France	13	69 0.2×	42 0.2×	136 0.7×	235 1.3×	180 3.1×	17	459
Bianca Alves Pauletti Brazil	16	45 0.1×	65 0.3×	363 1.9×	46 0.2×	59 1.0×	35	567
Thomas O. Kohl United States	12	92 0.3×	40 0.2×	281 1.5×	23 0.1×	37 0.6×	29	481
Graham Belfield United Kingdom	9	48 0.2×	32 0.1×	257 1.3×	27 0.1×	39 0.7×	19	362
Patrick Hossler United States	12	130 0.4×	47 0.2×	851 4.4×	86 0.5×	48 0.8×	14	909
Weijie Dong China	17	41 0.1×	53 0.2×	613 3.2×	30 0.2×	59 1.0×	32	784
Orli Yogev Israel	9	30 0.1×	29 0.1×	362 1.9×	72 0.4×	140 2.4×	11	645
Nikos Pagratis United States	15	24 0.1×	59 0.3×	430 2.2×	43 0.2×	27 0.5×	30	668

Countries citing papers authored by I. King

Since Specialization

Citations

This map shows the geographic impact of I. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. King more than expected).

Fields of papers citing papers by I. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. King. The network helps show where I. King may publish in the future.

Co-authorship network of co-authors of I. King

This figure shows the co-authorship network connecting the top 25 collaborators of I. King. A scholar is included among the top collaborators of I. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. King. I. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wisnewski, Adam V., et al.. (2016). Biotransformation and Rearrangement of Laromustine. Drug Metabolism and Disposition. 44(8). 1349–1363. 3 indexed citations

King, I., et al.. (2011). Characterization of Short-Lived Electrophilic Metabolites of the Anticancer Agent Laromustine (VNP40101M). Chemical Research in Toxicology. 24(4). 568–578. 3 indexed citations

Jian, Du, et al.. (2010). In Vitro Profiling and Mass Balance of the Anti-Cancer Agent Laromustine [14C]-VNP40101M by Rat, Dog, Monkey and Human Liver Microsomes. 4(1). 1–9. 2 indexed citations

Gelovani, Juri G., Ronald G. Blasberg, Xiaobo Luo, et al.. (2001). Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET™) for diagnostic imaging. Journal of Controlled Release. 74(1-3). 313–315. 50 indexed citations

Pichoud, Christian, Catherine Jamard, Sylviane Guérret, et al.. (2001). Antiviral Activity of β- l -2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus. Antimicrobial Agents and Chemotherapy. 45(4). 1065–1077. 35 indexed citations

Clairmont, Caroline, K. C. Lee, Jeremy A. Pike, et al.. (2000). Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain ofSalmonella typhimurium. The Journal of Infectious Diseases. 181(6). 1996–2002. 283 indexed citations

King, I., Xiang Luo, Ming Feng, et al.. (2000). Tumour therapy using Salmonella. 5(2). 211–219. 3 indexed citations

Li, Jun, Xiang Luo, Qin Wang, et al.. (1998). Synthesis and biological evaluation of a water soluble phosphate prodrug of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP). Bioorganic & Medicinal Chemistry Letters. 8(22). 3159–3164. 11 indexed citations

Kukhanova, Marina K., et al.. (1998). Interaction of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with human immunodeficiency virus-1 reverse transcriptase and human DNA polymerases: implications for human immunodeficiency virus drug design.. PubMed. 53(5). 801–7. 14 indexed citations

10.

King, I., C H Blood, Ming Chu, et al.. (1995). Antitumor effect of keto-diepoxides isolated from the fungus Nattrassia mangiferae.. PubMed. 7(1). 1–5. 1 indexed citations

11.

Li, Jiehui, I. King, & Alan C. Sartorelli. (1994). Differentiation of WEHI-3B D+ myelomonocytic leukemia cells induced by ectopic expression of the protooncogene c-jun.. PubMed. 5(7). 743–51. 27 indexed citations

12.

Violette, Shelia M., I. King, Jeffrey L. Browning, et al.. (1990). Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. Journal of Cellular Physiology. 142(1). 70–77. 94 indexed citations

13.

King, I. & Alan C. Sartorelli. (1989). Epidermal growth factor receptor gene expression, protein kinase activity, and terminal differentiation of human malignant epidermal cells.. PubMed. 49(20). 5677–81. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact